Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mehra

Showing results (431-440 of 780) with videos related to

Pageof 78
Sort By:
The American Journal of Cardiology|August 25, 2004
Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantationMandeep R Mehra, Patricia A Uber, Srinivasa Potluri, et al.
Drugs|July 23, 2020
Pharmaco-Immunomodulatory Therapy in COVID-19John G Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Optimizing heart transplant patient education: is once enough?A Bordelon, P A. Uber, D Dumas-Hicks, et al.
The American Journal of Cardiology|November 30, 2004
Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failureJamshid Alaeddini, Patricia A Uber, Myung H Park, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1988
A comparative analysis of signal averaging of the surface QRS complex and signal averaging of intracardiac and epicardial recordings in patients with ventricular tachycardiaJ A Gomes, R Mehra, P Barreca, et al.
Progress in Cardiovascular Diseases|March 25, 2020
Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathySaad I Mallah, Bassam Atallah, Fathi Moustafa, et al.
Progress in Cardiovascular Diseases|October 12, 2023
Outcomes of untreated subclinical antibody-mediated rejection after heart transplantationJacinthe Boulet, Jane Kelleher, Mauro R B Wanderley, et al.
The American Journal of Cardiology|December 14, 2002
Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic functionMyung H Park, Robert L Scott, Patricia A Uber, et al.
Drugs|September 4, 2020
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19"John G Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1997
The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisalM R Mehra, H O Ventura, R B Chambers, et al.
Pageof 78

Showing results (431-440 of 780) with videos related to

Sort By:
Pageof 78
The American Journal of Cardiology|August 25, 2004
Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantationMandeep R Mehra, Patricia A Uber, Srinivasa Potluri, et al.
Drugs|July 23, 2020
Pharmaco-Immunomodulatory Therapy in COVID-19John G Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Optimizing heart transplant patient education: is once enough?A Bordelon, P A. Uber, D Dumas-Hicks, et al.
The American Journal of Cardiology|November 30, 2004
Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failureJamshid Alaeddini, Patricia A Uber, Myung H Park, et al.
Pacing and Clinical Electrophysiology : PACE|March 1, 1988
A comparative analysis of signal averaging of the surface QRS complex and signal averaging of intracardiac and epicardial recordings in patients with ventricular tachycardiaJ A Gomes, R Mehra, P Barreca, et al.
Progress in Cardiovascular Diseases|March 25, 2020
Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathySaad I Mallah, Bassam Atallah, Fathi Moustafa, et al.
Progress in Cardiovascular Diseases|October 12, 2023
Outcomes of untreated subclinical antibody-mediated rejection after heart transplantationJacinthe Boulet, Jane Kelleher, Mauro R B Wanderley, et al.
The American Journal of Cardiology|December 14, 2002
Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic functionMyung H Park, Robert L Scott, Patricia A Uber, et al.
Drugs|September 4, 2020
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19"John G Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 1997
The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisalM R Mehra, H O Ventura, R B Chambers, et al.
Pageof 78